CapForce, Inc. (CFOR)
6.02
-0.88
(-12.75%)
USD |
OTCM |
Nov 05, 16:00
CapForce EPS Diluted (Quarterly) : 3.384 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.384 |
| March 31, 2026 | -0.0601 |
| December 31, 2025 | 2.068 |
| September 30, 2025 | -0.0604 |
| June 30, 2025 | 0.3432 |
| March 31, 2025 | -0.0405 |
| December 31, 2024 | 0.1576 |
| September 30, 2024 | 1.352 |
| June 30, 2024 | -1.176 |
| March 31, 2024 | 0.1528 |
| December 31, 2023 | -13.29 |
| September 30, 2023 | -4.628 |
| June 30, 2023 | -9.329 |
| March 31, 2023 | -12.53 |
| December 31, 2022 | -38.72 |
| September 30, 2022 | -59.19 |
| June 30, 2022 | -25.08 |
| March 31, 2022 | -29.27 |
| December 31, 2021 | -69.59 |
| September 30, 2021 | -31.65 |
| June 30, 2021 | -37.04 |
| March 31, 2021 | -100.73 |
| December 31, 2020 | -67.54 |
| September 30, 2020 | -80.30 |
| Date | Value |
|---|---|
| June 30, 2020 | -97.06 |
| March 31, 2020 | -106.84 |
| December 31, 2019 | -121.29 |
| September 30, 2019 | -789.42 |
| June 30, 2019 | -587.80 |
| March 31, 2019 | -1649.16 |
| December 31, 2018 | -1873.08 |
| September 30, 2018 | -2133.40 |
| June 30, 2018 | -2287.44 |
| March 31, 2018 | -3006.20 |
| December 31, 2017 | -5315.00 |
| September 30, 2017 | -7000.00 |
| June 30, 2017 | -372913.0 |
| March 31, 2017 | -19000.00 |
| December 31, 2016 | -21000.00 |
| September 30, 2016 | -23000.00 |
| June 30, 2016 | -37085.00 |
| March 31, 2016 | -36000.00 |
| December 31, 2015 | -38000.00 |
| September 30, 2015 | -38000.00 |
| June 30, 2015 | -84000.00 |
| March 31, 2015 | -25813.00 |
| December 31, 2013 | -38297.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | -0.3562 |
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 7.077 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.1417 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 42.47M |
| Revenue (Quarterly) | 50.00M |
| Total Expenses (Quarterly) | 7.529M |
| Enterprise Value | 76.45M |
| Gross Profit Margin (Quarterly) | 89.90% |
| Profit Margin (Quarterly) | 84.94% |
| Earnings Yield | 88.56% |
| Operating Earnings Yield | 96.42% |
| Normalized Earnings Yield | 88.56 |